Synapse - Darren Feldman

Results (349)

Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial

Meeting Abstract

Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis

Meeting Abstract

Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Hematologic malignancies arising in patients with germ cell tumors: Secondary somatic differentiation of hematopoietic malignancies from germ cell precursors

Meeting Abstract

Taylor, J.; Donoghue, M.; Rampal, R. K.; Tamari, R.; Tallman, M. S.; Feldman, D. R.; Taylor, B. S.; Abdel-Wahab, O. I.
Blood (2018)

Fulltext@MSK | Save

Comparative genomic profiling of matched primary and metastatic tumors in renal cell carcinoma

Journal Article

Becerra, M. F.; Reznik, E.; Redzematovic, A.; Tennenbaum, D. M.; Kashan, M.; Ghanaat, M.; Casuscelli, J.; Manley, B.; Jonsson, P.; DiNatale, R. G.; more...
European Urology Focus (2018)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: Subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial

Meeting Abstract

George, D. J.; Hessel, C.; Halabi, S.; Sanford, B. L.; Michaelson, M. D.; Hahn, O. M.; Walsh, M. K.; Olencki, T.; Picus, J.; Small, E. J.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

State-of-the-art management of germ cell tumors

Journal Article

Feldman, D. R.
American Society of Clinical Oncology Educational Book (2018)

Fulltext@MSK | Save

High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases